- CMS unveils enhanced 'Drug Dashboards' to increase transparency on drug prices
CMS unveils enhanced 'Drug Dashboards' to increase transparency on drug prices
CMS on Tuesday released a redesigned version of the Drug Spending Dashboards. For the first time, the dashboards include year-over-year information on drug pricing and highlight which manufactures have been increasing their prices. "Publishing how much individual drugs cost from one year to the next will provide much-needed clarity and will empower patients and doctors with the information they need," said CMS Administrator Seema Verma. The dashboards are interactive online tools that allow patients, clinicians, researchers, and the public to understand trends in drug spending. Data is reported for both Medicare and Medicaid. The new version of the dashboard reports the percentage change in spending on drugs per dosage unit and includes an expanded list of drugs.